Logo

Course

Developing Sex and Gender-tailored Strategies for Healthy Aging with HIV: The Effect of Low-level Viremia and Non-AIDS Comorbidity Burden

Details

Published Date: 12/06/2024

Expiration Date: 10/21/2027

CE Credit: CME:1

Description

As our patients with HIV are aging, we are well aware of the increased risks for non-AIDS comorbidities that interfere with both quality and\or duration of life. But are there sex and gender differences that can contribute to more precision-targeted outcomes in individual patients? Don’t miss this presentation by Dr. Lauren Collins, whose clinical and research interests focus on improving the care and outcomes of persons with HIV across the lifespan, and in particular, women and those affected by the HIV/AIDS epidemic.

Presenter(s)

Lauren F. Collins,MD, MSc

Lauren Collins (MD, MSc) is an Assistant Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine. She attends on the inpatient ID/HIV services at Grady Memorial Hospital and is a primary care physician at the Grady Ponce de Leon Center in the Adult and Women’s clinics. Since 2021, she has served as the Medical Director of the Grady Ponce Long-acting Antiretroviral Therapy Program. Dr. Collins’s clinical and research interests focus on improving the care and outcomes of persons with HIV across the lifespan, and in particular, women and those affected by the Southern HIV/AIDS epidemic. Her NIH K23 Award is focused on developing novel tools and strategies for aging-related multimorbidity screening and prevention in persons with HIV that are sex and gender tailored. She also leads a CDC U01 award that uses mixed methods to assess facilitators, barriers, and preferences for long-acting antiretroviral therapy use in cis-gender Black women with HIV in the South with the goal of promoting patient-centered and equitable scale-up of HIV treatment innovation.

Learning Objectives

  • Be able to describe the burden of non-AIDS comorbidities across the adult lifespan of persons with HIV with an emphasis on sex and gender differences including women’s health transitions.
  • Be able to evaluate sex and gender-specific and HIV-related factors contributing to comorbidity burden and implications for refined multimorbidity screening and prevention in this population.
  • Understand the prevalence and impact of low-level viremia in men and women living with HIV on virologic failure and multimorbidity.

Continuing Education Credit Information